One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-150751
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 10 |
Affiliation: Memorial Sloan Kettering Cancer Center, Cornell University, Cleveland Clinic, University of California, San Francisco, Columbia University Irving Medical Center, Oxford University Hospitals NHS Trust, Roswell Park Cancer Institute, Fred Hutch Cancer Center, Icahn School of Medicine at Mount Sinai, SUNY Upstate Medical University, Swedish Medical Center, Levine Cancer Institute, University of Virginia, Duke Medical Center, University of Colorado Denver, University of Colorado Cancer Center, University of North Carolina at Chapel Hill, University of Rochester, Novant Health, Moffitt Cancer Center, Northwell Health, Hospital of the University of Pennsylvania
Addressing a New Challenge in Chronic Lymphocytic Leukemia: Outcomes of Therapies after Exposure to Both a Covalent Bruton's Tyrosine Kinase Inhibitor and Venetoclax
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
